Business Description
Speciality Medicines Ltd
ISIN : INE0R0M01014
Total Employee Number:
18Compare
Compare
Traded in other countries / regions
544738.India IPO Date
2026-03-30Description
Speciality Medicines Ltd is engaged in the marketing and distribution of finished formulations of specialty pharmaceutical products, comprising oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases. Its product range includes various dosage forms such as tablets, capsules, syrups, injections, infusions, inhalers, sprays, and topical formulations. The company operates through two business models: (a) Manufacturing, through contract manufacturing basis, and (b) Marketing and distribution of specialty pharmaceutical products sourced from manufacturers. The majority of the company's revenue is derived from the sale of its projects, mainly through exports to other countries.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.7 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | 0.73 | |||||
Interest Coverage | 9.54 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 6.23 | |||||
Beneish M-Score | 0.43 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 63.9 | |||||
3-Year EBITDA Growth Rate | 76.1 | |||||
3-Year EPS without NRI Growth Rate | 118.4 | |||||
3-Year FCF Growth Rate | 22.4 | |||||
3-Year Book Growth Rate | 129 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 10.34 | |||||
9-Day RSI | 18.85 | |||||
14-Day RSI | 25.37 | |||||
3-1 Month Momentum % | -44.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.73 | |||||
Quick Ratio | 3.22 | |||||
Cash Ratio | 1.3 | |||||
Days Inventory | 254.65 | |||||
Days Sales Outstanding | 147.05 | |||||
Days Payable | 71.82 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 26.88 | |||||
Operating Margin % | 18.45 | |||||
Net Margin % | 18.27 | |||||
EBITDA Margin % | 20.21 | |||||
FCF Margin % | -2.88 | |||||
OCF Margin % | -2.86 | |||||
ROE % | 16.11 | |||||
ROA % | 12.1 | |||||
ROIC % | 17.11 | |||||
3-Year ROIIC % | 24.4 | |||||
ROC (Joel Greenblatt) % | 24.79 | |||||
ROCE % | 16.37 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.3 | |||||
PE Ratio without NRI | 12.3 | |||||
PS Ratio | 2.26 | |||||
PB Ratio | 1.9 | |||||
Price-to-Tangible-Book | 1.94 | |||||
EV-to-EBIT | 13.34 | |||||
EV-to-EBITDA | 13.23 | |||||
EV-to-Revenue | 2.68 | |||||
EV-to-FCF | -112.21 | |||||
Price-to-Graham-Number | 0.93 | |||||
| Price-to-Net-Current-Asset-Value | 2.12 | |||||
| Price-to-Net-Cash | 265.51 | |||||
Earnings Yield (Greenblatt) % | 7.49 | |||||
FCF Yield % | -0.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Speciality Medicines Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 447.834 | ||
| EPS (TTM) (₹) | 12.54 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 25.37 | ||
| 14-Day ATR (₹) | 6.865429 | ||
| 20-Day SMA (₹) | 181.115 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 121.1 - 381.2 | ||
| Shares Outstanding (Mil) | 8.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Speciality Medicines Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Speciality Medicines Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Speciality Medicines Ltd Frequently Asked Questions
What is Speciality Medicines Ltd(BOM:544738)'s stock price today?
The current price of BOM:544738 is ₹156.65. The 52 week high of BOM:544738 is ₹381.20 and 52 week low is ₹121.10.
When is next earnings date of Speciality Medicines Ltd(BOM:544738)?
The next earnings date of Speciality Medicines Ltd(BOM:544738) is .
Does Speciality Medicines Ltd(BOM:544738) pay dividends? If so, how much?
Speciality Medicines Ltd(BOM:544738) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Speciality Medicines Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers